Moonlake Immunotherapeutics (MLTX) PT Raised to $45 at Clear Street
Tweet Send to a Friend
Clear Street analyst Kaveri Pohlman raised the price target on Moonlake Immunotherapeutics (NASDAQ: MLTX) to $45.00 (from $12.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
